Andrew Hedin

Andrew Hedin

Direktör/Styrelseledamot på
Nido Biosciences, Inc.
41 år
Health Technology
Finance
Consumer Services

Profil

Andrew Hedin is a partner in Bessemer’s Cambridge office where he focuses on investments broadly across the healthcare ecosystem, including new biotech therapeutics as well as software and services sold to healthcare verticals.
Prior to joining Bessemer in 2015, Andrew worked at F-Prime Capital, Fidelity’s healthcare-focused venture capital fund where he invested in early-stage biotech and digital health technologies, as well as Leerink Partners as an advisor to the biopharma industry.
He earned an MBA with honors from The Wharton School, where he majored in health care management and finance, as well as a degree in biological basis of behavior from the University of Pennsylvania.

Aktiva positioner av Andrew Hedin

FöretagPositionStart
Privat kapitalinvesterare 2015-07-01
Direktör/Styrelseledamot -

Tidigare kända positioner av Andrew Hedin

FöretagPositionSlut
KYMERA THERAPEUTICS, INC. Direktör/Styrelseledamot 2021-06-16
Private Equity-analytiker 2013-07-30
TSCAN THERAPEUTICS, INC. Direktör/Styrelseledamot -
Företagsledare/Principal -
Se detaljerna i Andrew Hedins erfarenhet

Andrew Hedins utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

89

Första gradens relationer

8

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag8

Consumer Services

Finance

Finance

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Andrew Hedin